On September 27, 2022 Imunon, Inc. (NASDAQ: IMNN), a clinical-stage drug development company, reported that Dr. Corinne Le Goff, President and Chief Executive Officer will present a company overview and be available for 1×1 meetings at the upcoming Chardan 6th Annual Genetic Medicines Conference (Press release, IMUNON, SEP 27, 2022, View Source [SID1234621459]). The conference will be held on October 3-4 with in-person participation held at the Westin Grand Central Hotel in New York City.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Dr. Le Goff will present in person on Monday, October 3rd at 2:30 pm ET. The presentation will available live and on-demand here.